Market Research Logo

Cholesterol Lowering Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

Cholesterol Lowering Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

The report on the global cholesterol lowering drug market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global cholesterol lowering drug market to grow with a Healthy CAGR over the forecast period from 2018-2024. The study on cholesterol lowering drug market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.
The report on cholesterol lowering drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cholesterol lowering drug market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cholesterol lowering drug market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Growth In The Intake Of Saturated And Trans Fat And Tobacco Smoking
• Growing Occurrences Of High-density Lipoproteins (HDL)cholesterol And Cardiac Diseases
2) Restraints
• Risks Of Side-effects
3) Opportunities
• Growing Spending Capacity On Healthcare
• Increasing Aging Population

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global cholesterol lowering drug market is segmented on the basis of class of drugs.

The Global Cholesterol Lowering Drug Market by Class of Drugs
• Statins
• Fixed-Dose Combinations
• Cholesterol Absorption Inhibitors
• Ion Exchange Resins
• Fibrates
• PCSK9 Inhibitors
• Novel Cholesterol-Lowering Drugs

Company Profiles
The companies covered in the report include
• AstraZeneca
• Amgen
• Merck and Co.
• Daiichi Sankyo
• Bristol-Myers Squibb
• Pfizer
• Kowa Company, Ltd.
• AbbVie
• Sanofi
• Novartis

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the cholesterol lowering drug market.
2. Complete coverage of all the segments in the cholesterol lowering drug market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global cholesterol lowering drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on cholesterol lowering drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cholesterol lowering drug market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Cholesterol Lowering Drug Market Highlights
2.2. Cholesterol Lowering Drug Market Projection
2.3. Cholesterol Lowering Drug Market Regional Highlights
3. Global Cholesterol Lowering Drug Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Class of Drugs
3.4.2. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cholesterol Lowering Drug Market
4. Cholesterol Lowering Drug Market Macro Indicator Analysis
5. Global Cholesterol Lowering Drug Market by Class of Drugs
5.1. Statins
5.2. Fixed-Dose Combinations
5.3. Cholesterol Absorption Inhibitors
5.4. Ion Exchange Resins
5.5. Fibrates
5.6. PCSK9 Inhibitors
5.7. Novel Cholesterol-Lowering Drugs
6. Global Cholesterol Lowering Drug Market by Region 2018-2024
6.1. North America
6.1.1. North America Cholesterol Lowering Drug Market by Class of Drugs
6.1.2. North America Cholesterol Lowering Drug Market by Country
6.2. Europe
6.2.1. Europe Cholesterol Lowering Drug Market by Class of Drugs
6.2.2. Europe Cholesterol Lowering Drug Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Cholesterol Lowering Drug Market by Class of Drugs
6.3.2. Asia-Pacific Cholesterol Lowering Drug Market by Country
6.4. RoW
6.4.1. RoW Cholesterol Lowering Drug Market by Class of Drugs
6.4.2. RoW Cholesterol Lowering Drug Market by Sub-region
7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Cholesterol Lowering Drug Market
7.2. Companies Profiles
7.2.1. AstraZeneca
7.2.1.1. Overview
7.2.1.2. Company Snapshot
7.2.1.3. Financial Snapshot
7.2.1.4. Product Portfolio
7.2.1.5. Recent Developments
7.2.2. Amgen
7.2.2.1. Overview
7.2.2.2. Company Snapshot
7.2.2.3. Financial Snapshot
7.2.2.4. Product Portfolio
7.2.2.5. Recent Developments
7.2.3. Merck and Co.
7.2.3.1. Overview
7.2.3.2. Company Snapshot
7.2.3.3. Financial Snapshot
7.2.3.4. Product Portfolio
7.2.3.5. Recent Developments
7.2.4. Daiichi Sankyo
7.2.4.1. Overview
7.2.4.2. Company Snapshot
7.2.4.3. Financial Snapshot
7.2.4.4. Product Portfolio
7.2.4.5. Recent Developments
7.2.5. Bristol-Myers Squibb
7.2.5.1. Overview
7.2.5.2. Company Snapshot
7.2.5.3. Financial Snapshot
7.2.5.4. Product Portfolio
7.2.5.5. Recent Developments
7.2.6. Pfizer
7.2.6.1. Overview
7.2.6.2. Company Snapshot
7.2.6.3. Financial Snapshot
7.2.6.4. Product Portfolio
7.2.6.5. Recent Developments
7.2.7. Kowa Company, Ltd.
7.2.7.1. Overview
7.2.7.2. Company Snapshot
7.2.7.3. Financial Snapshot
7.2.7.4. Product Portfolio
7.2.7.5. Recent Developments
7.2.8. AbbVie
7.2.8.1. Overview
7.2.8.2. Company Snapshot
7.2.8.3. Financial Snapshot
7.2.8.4. Product Portfolio
7.2.8.5. Recent Developments
7.2.9. Sanofi
7.2.9.1. Overview
7.2.9.2. Company Snapshot
7.2.9.3. Financial Snapshot
7.2.9.4. Product Portfolio
7.2.9.5. Recent Developments
7.2.10. Novartis
7.2.10.1. Overview
7.2.10.2. Company Snapshot
7.2.10.3. Financial Snapshot
7.2.10.4. Product Portfolio
7.2.10.5. Recent Developments
8. Appendix
8.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report